DE69936994D1 - Verfahren zur behandlung von okularen neovaskularen erkrankungen - Google Patents

Verfahren zur behandlung von okularen neovaskularen erkrankungen

Info

Publication number: DE69936994D1
Authority: DE; Germany
Prior art keywords: treatment; ocular neovascular; neovascular diseases; diseases; ocular
Prior art date: 1998-08-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69936994T

Other languages

English (en)

Other versions

DE69936994T2 (de

Inventor

Romulus Kimbro Brazzell

Jeanette Marjorie Wood

Peter Anthony Campochiaro

Frances Elizabeth Kane

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Novartis AG

Original Assignee

Novartis AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-13

Filing date

1999-08-11

Publication date

2007-10-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22460608&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69936994(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-08-11 Application filed by Novartis AG filed Critical Novartis AG

2007-10-11 Application granted granted Critical

2007-10-11 Publication of DE69936994D1 publication Critical patent/DE69936994D1/de

2008-06-05 Publication of DE69936994T2 publication Critical patent/DE69936994T2/de

2019-08-12 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DE69936994T 1998-08-13 1999-08-11 Verfahren zur behandlung von okularen neovaskularen erkrankungen Expired - Lifetime DE69936994T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US133855		1987-12-16
US13385598A	1998-08-13	1998-08-13
PCT/EP1999/005876 WO2000009098A2 (en)	1998-08-13	1999-08-11	Method for treating ocular neovascular diseases

Publications (2)

Publication Number	Publication Date
DE69936994D1 true DE69936994D1 (de)	2007-10-11
DE69936994T2 DE69936994T2 (de)	2008-06-05

Family

ID=22460608

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69936994T Expired - Lifetime DE69936994T2 (de)	1998-08-13	1999-08-11	Verfahren zur behandlung von okularen neovaskularen erkrankungen

Country Status (12)

Country	Link
EP (1)	EP1105136B1 (de)
JP (1)	JP2002522475A (de)
AR (1)	AR028802A1 (de)
AT (1)	ATE371453T1 (de)
AU (1)	AU5733099A (de)
CY (1)	CY1107780T1 (de)
DE (1)	DE69936994T2 (de)
DK (1)	DK1105136T3 (de)
ES (1)	ES2291041T3 (de)
PT (1)	PT1105136E (de)
TW (1)	TWI239243B (de)
WO (1)	WO2000009098A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CO4950519A1 (es) *	1997-02-13	2000-09-01	Novartis Ag	Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion
US6294532B1 (en)	1997-08-22	2001-09-25	Zeneca Limited	Oxindolylquinazoline derivatives as angiogenesis inhibitors
DE60028740T2 (de) *	1999-03-30	2007-05-24	Novartis Ag	Phthalazinderivate zur behandlung von entzündlichen erkrankungen
US7087608B2 (en) *	2000-03-03	2006-08-08	Robert Charles Atkins	Use of PDGF receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
DK1401415T3 (da)	2001-06-29	2006-10-16	Ab Science	Anvendelse af N-phenyl-2-pyrimidinamin-derivater til behandling af inflammatoriske sygdomme
JP2004537536A (ja)	2001-06-29	2004-12-16	アブサイエンス	アレルギー疾患を治療するためのチロシンキナーゼ阻害剤の使用方法
ATE343415T1 (de)	2001-06-29	2006-11-15	Ab Science	Die verwendung von c-kit hemmer zur behandlung von entzündlichen darmerkrankungen
US7727731B2 (en)	2001-06-29	2010-06-01	Ab Science	Potent, selective and non toxic c-kit inhibitors
GB0122318D0 (en) *	2001-09-14	2001-11-07	Novartis Ag	Organic compounds
JP2005511596A (ja) *	2001-09-20	2005-04-28	アブサイエンス	ヒトの皮膚を白くし、且つメラノサイト機能不全関連疾病を治療するためのチロシンキナーゼ阻害剤の使用方法
PL371466A1 (en) *	2002-02-28	2005-06-13	Novartis Ag	N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents
WO2003092696A1 (en) *	2002-04-30	2003-11-13	Novartis Ag	Method for decreasing capillary permeability in the retina
EP2125895B1 (de)	2007-02-02	2015-04-08	Vegenics Pty Ltd	Vegf-rezeptorantagonisten zur behandlung von allommunität bei organtransplantationen und atherosklerose

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH09316099A (ja) *	1995-08-21	1997-12-09	Mitsui Petrochem Ind Ltd	抗ｖｅｇｆヒトモノクローナル抗体
WO1997034876A1 (en) *	1996-03-15	1997-09-25	Zeneca Limited	Cinnoline derivatives and use as medicine
AU2066797A (en) *	1996-03-21	1997-10-10	Sugen, Inc.	Assays for kdr/flk-1 receptor tyrosine kinase inhibitors
UA54427C2 (uk) *	1996-05-01	2003-03-17	Елі Ліллі Енд Компані	Спосіб лікування очних захворювань, які пов'язані з фактором васкулярного ендотеліального росту
JPH1031019A (ja) *	1996-07-15	1998-02-03	Toagosei Co Ltd	糖尿病性血管新生緑内障の検査方法及び検査薬
CN1252054C (zh) *	1996-09-25	2006-04-19	曾尼卡有限公司	抑制生长因子的作用的喹啉衍生物
CO4950519A1 (es) *	1997-02-13	2000-09-01	Novartis Ag	Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion

1999
- 1999-08-11 AU AU57330/99A patent/AU5733099A/en not_active Abandoned
- 1999-08-11 AR ARP990104021A patent/AR028802A1/es unknown
- 1999-08-11 EP EP99944371A patent/EP1105136B1/de not_active Expired - Lifetime
- 1999-08-11 DE DE69936994T patent/DE69936994T2/de not_active Expired - Lifetime
- 1999-08-11 AT AT99944371T patent/ATE371453T1/de not_active IP Right Cessation
- 1999-08-11 WO PCT/EP1999/005876 patent/WO2000009098A2/en not_active Ceased
- 1999-08-11 ES ES99944371T patent/ES2291041T3/es not_active Expired - Lifetime
- 1999-08-11 DK DK99944371T patent/DK1105136T3/da active
- 1999-08-11 JP JP2000564601A patent/JP2002522475A/ja not_active Withdrawn
- 1999-08-11 PT PT99944371T patent/PT1105136E/pt unknown
- 1999-08-12 TW TW088113778A patent/TWI239243B/zh not_active IP Right Cessation
2007
- 2007-10-25 CY CY20071101385T patent/CY1107780T1/el unknown

Also Published As

Publication number	Publication date
ES2291041T3 (es)	2008-02-16
DE69936994T2 (de)	2008-06-05
EP1105136B1 (de)	2007-08-29
AR028802A1 (es)	2003-05-28
WO2000009098A2 (en)	2000-02-24
TWI239243B (en)	2005-09-11
ATE371453T1 (de)	2007-09-15
DK1105136T3 (da)	2007-10-15
PT1105136E (pt)	2007-12-03
EP1105136A2 (de)	2001-06-13
AU5733099A (en)	2000-03-06
JP2002522475A (ja)	2002-07-23
WO2000009098A3 (en)	2000-05-18
CY1107780T1 (el)	2013-06-19

Publication	Publication Date	Title
DE69939058D1 (de)	2008-08-21	Vorrichtung zur behandlung von peripheren gefässerkrankungen
DE69806970D1 (de)	2002-09-05	Verfahren zur behandlung von hartgeweben
ATE271038T1 (de)	2004-07-15	4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
DE60042611D1 (de)	2009-09-03	Verfahren zur behandlung von gefässerkrankungen, dxid auszeichnen
ATE417602T1 (de)	2009-01-15	Mittel zur behandlung von erkrankungen der speiseröhre
DE69925266D1 (de)	2005-06-16	Verfahren und gerät zur behandlung von herzarhythmie
DE69925609D1 (de)	2005-07-07	Verfahren zur textilbehandlung
DE69838789D1 (de)	2008-01-10	Verfahren zur behandlung oder prävention der alzheimerischen krankheit
EP0820467A4 (de)	2001-12-05	Verfahren zur behandlung von augenkrankheiten
DE69534701D1 (de)	2006-01-26	Verfahren zur behandlung von entzündlichen gelenkerkrankungen
DE69814467D1 (de)	2003-06-12	Verfahren zur prophylaktischen behandlung von mastitis
DE60223688D1 (de)	2008-01-03	Verfahren zur behandlung von multiplem myelom
DE69937624D1 (de)	2008-01-10	Verfahren zur Behandlung von Metalloberflächen
DE60035326D1 (de)	2007-08-09	Verfahren zur Behandlung von Abwasser
DE69626311D1 (de)	2003-03-27	Zusammensetzung zur behandlung von wäsche sowie verfahren hierfür
DE69936994D1 (de)	2007-10-11	Verfahren zur behandlung von okularen neovaskularen erkrankungen
DE69943089D1 (de)	2011-02-10	Methode zur behandlung von staphylokokkeninfektionen
DE69835419D1 (de)	2006-09-14	Verfahren zur Behandlung von organischem Abwasser
DE60136748D1 (de)	2009-01-08	Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
DE69702997D1 (de)	2000-10-12	Verfahren zur Behandlung von verunreinigtem Aluminiumoxid
DE69834578D1 (de)	2006-06-22	Verfahren zur behandlung von zementaufschlämmungen
ATE222910T1 (de)	2002-09-15	Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69607559D1 (de)	2000-05-11	Verfahren zur Behandlung von Phenolteer
DE60021948D1 (de)	2005-09-22	Verfahren zur Behandlung von Kontaktlinsen
DE69822297D1 (de)	2004-04-15	Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten

Legal Events

Date	Code	Title	Description
2008-09-18	8364	No opposition during term of opposition
2010-05-20	8328	Change in the person/name/address of the agent	Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336
2011-06-16	8328	Change in the person/name/address of the agent	Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN